Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: A prespecified subgroup analysis of a community-based, randomized, open-label trial

Brendan M. Everett; Robert J. Glynn; Eleanor Danielson; Paul M Ridker

doi:10.1016/j.clinthera.2008.04.013

Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: A prespecified subgroup analysis of a community-based, randomized, open-label trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.04.013 ◽

2008 ◽

Vol 30 (4) ◽

pp. 661-672 ◽

Cited By ~ 21

Author(s):

Brendan M. Everett ◽

Robert J. Glynn ◽

Eleanor Danielson ◽

Paul M Ridker

Keyword(s):

Combination Therapy ◽

Subgroup Analysis ◽

Initial Treatment ◽

Open Label ◽

Community Based ◽

Open Label Trial

Download Full-text

Phase II, Randomized, Open-Label, Community-Based Trial to Compare the Safety and Activity of Combination Therapy With Recombinant Interferon-α2b and Zidovudine Versus Zidovudine Alone in Patients With Asymptomatic to Mildly Symptomatic HIV Infection

Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ◽

10.1097/00042560-199903010-00005 ◽

1999 ◽

Vol 20 (3) ◽

pp. 245-254 ◽

Cited By ~ 10

Author(s):

Susan E. Krown ◽

Dorothee Aeppli ◽

Henry H. Balfour

Keyword(s):

Combination Therapy ◽

Hiv Infection ◽

Phase Ii ◽

Open Label ◽

Community Based ◽

Recombinant Interferon ◽

Interferon Α2b

Download Full-text

An open-label trial of combination therapy with interferon β-1a and oral methotrexate in MS

Neurology ◽

10.1212/wnl.58.2.314 ◽

2002 ◽

Vol 58 (2) ◽

pp. 314-317 ◽

Cited By ~ 59

Author(s):

P. A. Calabresi ◽

J. L. Wilterdink ◽

J. M. Rogg ◽

P. Mills ◽

A. Webb ◽

...

Keyword(s):

Combination Therapy ◽

Interferon Β ◽

Open Label ◽

Oral Methotrexate ◽

Open Label Trial

Download Full-text

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

The Lancet ◽

10.1016/s0140-6736(09)60953-3 ◽

2009 ◽

Vol 373 (9681) ◽

pp. 2125-2135 ◽

Cited By ~ 919

Author(s):

Philip D Home ◽

Stuart J Pocock ◽

Henning Beck-Nielsen ◽

Paula S Curtis ◽

Ramon Gomis ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Cardiovascular Outcomes ◽

Oral Agent ◽

Open Label ◽

Open Label Trial

Download Full-text

Lithium Plus Valproate Combination Therapy Versus Monotherapy for Relapse Prevention in Bipolar I Disorder (BALANCE): A Randomised Open-Label Trial

FOCUS The Journal of Lifelong Learning in Psychiatry ◽

10.1176/appi.focus.9.4.488 ◽

2011 ◽

Vol 9 (4) ◽

pp. 488

Keyword(s):

Combination Therapy ◽

Relapse Prevention ◽

Open Label ◽

Bipolar I Disorder ◽

Open Label Trial

Download Full-text

Faculty Opinions recommendation of Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2036975.793539087 ◽

2017 ◽

Author(s):

Janusz Rybakowski

Keyword(s):

Combination Therapy ◽

Relapse Prevention ◽

Open Label ◽

Bipolar I Disorder ◽

Open Label Trial

Download Full-text

Faculty Opinions recommendation of Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2036975.1615076 ◽

2010 ◽

Author(s):

Rudolf Uher ◽

Nader Perroud

Keyword(s):

Combination Therapy ◽

Relapse Prevention ◽

Open Label ◽

Bipolar I Disorder ◽

Open Label Trial

Download Full-text

Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial

10.1183/13993003.congress-2015.oa4996 ◽

2015 ◽

Author(s):

Paul Hassoun ◽

Roham Zamanian ◽

Rachel Damico ◽

Rubina Khair ◽

Todd Kolb ◽

...

Keyword(s):

Pulmonary Arterial Hypertension ◽

Combination Therapy ◽

Arterial Hypertension ◽

Open Label ◽

Pulmonary Arterial ◽

Open Label Trial

Download Full-text

Lithium Plus Valproate Combination Therapy Versus Monotherapy for Relapse Prevention in Bipolar I Disorder (BALANCE): A Randomised Open-Label Trial

FOCUS The Journal of Lifelong Learning in Psychiatry ◽

10.1176/foc.9.4.foc488 ◽

2011 ◽

Vol 9 (4) ◽

pp. 488-499 ◽

Cited By ~ 1

Author(s):

◽

John R. Geddes ◽

Guy M. Goodwin ◽

Jennifer Rendell ◽

John-Michel Azorin ◽

...

Keyword(s):

Combination Therapy ◽

Relapse Prevention ◽

Open Label ◽

Bipolar I Disorder ◽

Open Label Trial

Download Full-text

CMET-39. INTRA-CSF LIPOSOMAL CYTARABINE PLUS SYSTEMIC THERAPY AS INITIAL TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS: A RANDOMISED, OPEN-LABEL TRIAL

Neuro-Oncology ◽

10.1093/neuonc/noy148.249 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi61-vi62

Author(s):

Emilie Le Rhun ◽

Audrey Mailliez ◽

Jennifer Wallet ◽

Isabelle Rodrigues ◽

Thomas Boulanger ◽

...

Keyword(s):

Breast Cancer ◽

Systemic Therapy ◽

Initial Treatment ◽

Leptomeningeal Metastasis ◽

Liposomal Cytarabine ◽

Open Label ◽

Open Label Trial

Download Full-text

A Large, Community-Based, Open-Label Trial of Donepezil in the Treatment of Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders ◽

10.1159/000069988 ◽

2003 ◽

Vol 16 (1) ◽

pp. 15-24 ◽

Cited By ~ 25

Author(s):

Norman R. Relkin ◽

William E. Reichman ◽

John Orazem ◽

Thomas McRae

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Open Label ◽

Community Based ◽

Large Community ◽

Open Label Trial

Download Full-text